NASDAQ
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) has a eps (diluted) of $269.27 as of Saturday, February 28, 2026. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.